Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds.
AD pathophysiology
Affinity proteomics
Brain-enriched proteins
CSF markers
Multidisciplinary epidemiological studies
Preclinical Alzheimer’s disease
Journal
Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643
Informations de publication
Date de publication:
02 03 2021
02 03 2021
Historique:
received:
25
11
2020
accepted:
11
02
2021
entrez:
3
3
2021
pubmed:
4
3
2021
medline:
25
6
2021
Statut:
epublish
Résumé
Increased knowledge of the evolution of molecular changes in neurodegenerative disorders such as Alzheimer's disease (AD) is important for the understanding of disease pathophysiology and also crucial to be able to identify and validate disease biomarkers. While several biological changes that occur early in the disease development have already been recognized, the need for further characterization of the pathophysiological mechanisms behind AD still remains. In this study, we investigated cerebrospinal fluid (CSF) levels of 104 proteins in 307 asymptomatic 70-year-olds from the H70 Gothenburg Birth Cohort Studies using a multiplexed antibody- and bead-based technology. The protein levels were first correlated with the core AD CSF biomarker concentrations of total tau, phospho-tau and amyloid beta (Aβ42) in all individuals. Sixty-three proteins showed significant correlations to either total tau, phospho-tau or Aβ42. Thereafter, individuals were divided based on CSF Aβ42/Aβ40 ratio and Clinical Dementia Rating (CDR) score to determine if early changes in pathology and cognition had an effect on the correlations. We compared the associations of the analysed proteins with CSF markers between groups and found 33 proteins displaying significantly different associations for amyloid-positive individuals and amyloid-negative individuals, as defined by the CSF Aβ42/Aβ40 ratio. No differences in the associations could be seen for individuals divided by CDR score. We identified a series of transmembrane proteins, proteins associated with or anchored to the plasma membrane, and proteins involved in or connected to synaptic vesicle transport to be associated with CSF biomarkers of amyloid and tau pathology in AD. Further studies are needed to explore these proteins' role in AD pathophysiology.
Sections du résumé
BACKGROUND
Increased knowledge of the evolution of molecular changes in neurodegenerative disorders such as Alzheimer's disease (AD) is important for the understanding of disease pathophysiology and also crucial to be able to identify and validate disease biomarkers. While several biological changes that occur early in the disease development have already been recognized, the need for further characterization of the pathophysiological mechanisms behind AD still remains.
METHODS
In this study, we investigated cerebrospinal fluid (CSF) levels of 104 proteins in 307 asymptomatic 70-year-olds from the H70 Gothenburg Birth Cohort Studies using a multiplexed antibody- and bead-based technology.
RESULTS
The protein levels were first correlated with the core AD CSF biomarker concentrations of total tau, phospho-tau and amyloid beta (Aβ42) in all individuals. Sixty-three proteins showed significant correlations to either total tau, phospho-tau or Aβ42. Thereafter, individuals were divided based on CSF Aβ42/Aβ40 ratio and Clinical Dementia Rating (CDR) score to determine if early changes in pathology and cognition had an effect on the correlations. We compared the associations of the analysed proteins with CSF markers between groups and found 33 proteins displaying significantly different associations for amyloid-positive individuals and amyloid-negative individuals, as defined by the CSF Aβ42/Aβ40 ratio. No differences in the associations could be seen for individuals divided by CDR score.
CONCLUSIONS
We identified a series of transmembrane proteins, proteins associated with or anchored to the plasma membrane, and proteins involved in or connected to synaptic vesicle transport to be associated with CSF biomarkers of amyloid and tau pathology in AD. Further studies are needed to explore these proteins' role in AD pathophysiology.
Identifiants
pubmed: 33653397
doi: 10.1186/s13195-021-00789-5
pii: 10.1186/s13195-021-00789-5
pmc: PMC7923505
doi:
Substances chimiques
Amyloid beta-Peptides
0
Biomarkers
0
Cerebrospinal Fluid Proteins
0
Peptide Fragments
0
tau Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
54Références
Crit Rev Clin Lab Sci. 2020 Mar;57(2):86-98
pubmed: 31694431
J Med Genet. 2011 Jan;48(1):48-54
pubmed: 20972252
Alzheimers Dement. 2015 Oct;11(10):1180-90
pubmed: 25533203
Alzheimers Res Ther. 2018 Jan 15;10(1):5
pubmed: 29370833
Proteomics Clin Appl. 2016 Dec;10(12):1242-1253
pubmed: 27604409
Proteomics. 2013 Aug;13(15):2256-67
pubmed: 23696371
J Neurol Neurosurg Psychiatry. 2020 Dec 30;:
pubmed: 33380492
Development. 2010 Feb;137(3):427-35
pubmed: 20056680
Expert Rev Neurother. 2017 Jan;17(1):47-57
pubmed: 27332958
Acta Neuropathol. 2010 Jun;119(6):669-78
pubmed: 20232070
Transl Neurodegener. 2020 Jun 23;9(1):27
pubmed: 32576262
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
J Proteomics. 2011 Apr 1;74(4):371-88
pubmed: 21111852
Science. 2019 Dec 20;366(6472):
pubmed: 31857451
PLoS One. 2013 May 21;8(5):e63589
pubmed: 23704923
Alzheimers Res Ther. 2017 Jul 3;9(1):48
pubmed: 28673336
Mov Disord. 2020 Nov;35(11):2101-2106
pubmed: 33179332
Nat Neurosci. 2001 Jan;4(1):38-43
pubmed: 11135643
BMJ. 1995 Jan 21;310(6973):170
pubmed: 7833759
Neurology. 2001 Jan 9;56(1):127-9
pubmed: 11148253
Neuron. 2018 Dec 19;100(6):1322-1336.e7
pubmed: 30392797
Biochimie. 1997 Jun;79(6):373-84
pubmed: 9310187
Neurology. 2007 May 1;68(18):1501-8
pubmed: 17470753
J Proteome Res. 2018 Dec 7;17(12):4315-4319
pubmed: 30106588
J Clin Pathol. 2019 Nov;72(11):725-735
pubmed: 31395625
JAMA Neurol. 2016 Jan;73(1):60-7
pubmed: 26524180
Proteomics. 2007 Feb;7(3):469-73
pubmed: 17211832
Methods Mol Biol. 2019;2044:303-318
pubmed: 31432421
Neuron. 2015 Mar 18;85(6):1257-72
pubmed: 25754824
Elife. 2016 Jan 23;5:
pubmed: 26802628
Sci Rep. 2016 Jun 07;6:27343
pubmed: 27273464
Alzheimers Res Ther. 2018 Jan 23;10(1):8
pubmed: 29370869
PLoS One. 2010 Jun 11;5(6):e10980
pubmed: 20552007
Alzheimers Dement. 2019 Jan;15(1):55-64
pubmed: 30321501
J Proteome Res. 2008 Aug;7(8):3168-79
pubmed: 18588325
Transl Neurosci. 2015 Oct 23;6(1):214-226
pubmed: 28123806
J Alzheimers Dis. 2020;73(4):1585-1595
pubmed: 31958084
JAMA Neurol. 2019 Sep 1;76(9):1035-1048
pubmed: 31206160
J Comp Neurol. 2015 Jan 1;523(1):75-92
pubmed: 25158904
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
Mol Neurobiol. 2018 Apr;55(4):3021-3032
pubmed: 28456942
J Biochem. 2003 Aug;134(2):231-8
pubmed: 12966072
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1971-6
pubmed: 19188609
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
Biochem Pharmacol. 2004 Sep 15;68(6):1049-53
pubmed: 15313400
Alzheimers Res Ther. 2018 Jul 18;10(1):66
pubmed: 30021611
J Exp Med. 2014 Mar 10;211(3):387-93
pubmed: 24534188
Annu Rev Pathol. 2006;1:151-70
pubmed: 18039111
Neurobiol Aging. 2010 Jul;31(7):1145-52
pubmed: 18771816
Eur J Epidemiol. 2019 Feb;34(2):191-209
pubmed: 30421322
Eur J Hum Genet. 2015 May;23(5):628-32
pubmed: 25074461
Acta Neuropathol Commun. 2019 Nov 6;7(1):169
pubmed: 31694701
Bioinformatics. 2018 Mar 01;34(5):721-724
pubmed: 29088312
J Proteome Res. 2016 Oct 7;15(10):3473-3480
pubmed: 27570895
J Biol Chem. 2012 Jul 27;287(31):25927-40
pubmed: 22692213
J Alzheimers Dis. 2016 Mar 15;52(1):179-90
pubmed: 27003210
Front Cell Neurosci. 2017 Aug 31;11:266
pubmed: 28912688
J Biol Chem. 2000 Jun 9;275(23):17583-9
pubmed: 10748223
Exp Gerontol. 2012 May;47(5):347-52
pubmed: 21983493
Brain Res. 2019 Oct 1;1720:146305
pubmed: 31247206
J Neurosci. 2014 Jul 9;34(28):9364-76
pubmed: 25009269
Brain. 2015 Nov;138(Pt 11):3373-85
pubmed: 26373605
Neurology. 2016 Mar 1;86(9):829-35
pubmed: 26826204
Sci Rep. 2018 Nov 26;8(1):17368
pubmed: 30478269
Genes Dev. 2019 Mar 1;33(5-6):365-376
pubmed: 30808661
Ann Neurol. 1990 May;27(5):457-64
pubmed: 2360787
Neuron. 2018 May 16;98(4):861-864
pubmed: 29772204
Sci Data. 2017 Aug 29;4:170112
pubmed: 28850106
Cell Adh Migr. 2015;9(3):193-201
pubmed: 25837840
Neurology. 2017 Oct 24;89(17):1782-1788
pubmed: 28939668
J Biol Chem. 2004 Mar 26;279(13):13065-75
pubmed: 14722103
Stem Cells Int. 2019 May 2;2019:2054783
pubmed: 31191667
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):E5343-E5351
pubmed: 28634303
Mol Cell Proteomics. 2016 Oct;15(10):3126-3138
pubmed: 27507836
Cell Rep. 2016 May 17;15(7):1455-1466
pubmed: 27160897
J Neurosci. 2014 Aug 20;34(34):11274-87
pubmed: 25143608
Neuroreport. 2012 Nov 14;23(16):942-6
pubmed: 22975846
Biochim Biophys Acta. 2013 Jul;1828(7):1541-9
pubmed: 23196350
Neuron. 2008 Apr 10;58(1):42-51
pubmed: 18400162
J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):846-853
pubmed: 31097472
Am J Pathol. 2008 Jun;172(6):1683-92
pubmed: 18467692
Acta Med Okayama. 2009 Dec;63(6):305-23
pubmed: 20035287
J Neurosci Res. 1992 Sep;33(1):177-87
pubmed: 1453482
J Alzheimers Dis. 2019;67(2):639-651
pubmed: 30614806
PLoS One. 2010 Aug 11;5(8):e12018
pubmed: 20711454
Anesth Analg. 2018 May;126(5):1763-1768
pubmed: 29481436
PLoS One. 2010 Jan 25;5(1):e8856
pubmed: 20111594
Clin Chim Acta. 2019 Jul;494:79-93
pubmed: 30858094
Acta Neuropathol. 2019 Jan;137(1):89-102
pubmed: 30244311
Neurology. 2018 May 8;90(19):e1682-e1691
pubmed: 29653987
F1000Res. 2018 Jul 5;7:1012
pubmed: 30191060
Clin Chem. 2018 Jun;64(6):927-937
pubmed: 29523639
EMBO J. 2001 Aug 15;20(16):4332-6
pubmed: 11500359
Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Dec 18;40(6):572-7
pubmed: 19088825
Science. 2020 Mar 6;367(6482):
pubmed: 32139519
J Proteomics. 2015 Apr 24;119:90-9
pubmed: 25661039
Mol Cell Proteomics. 2019 Mar;18(3):546-560
pubmed: 30606734
Dementia. 1996 Jul-Aug;7(4):226-32
pubmed: 8835888
Acta Neuropathol. 2009 Jul;118(1):167-79
pubmed: 19390859
Mol Neurodegener. 2014 Jun 06;9:22
pubmed: 24902845
Mol Cell Neurosci. 2002 Aug;20(4):595-615
pubmed: 12213442
Eur J Neurosci. 2002 Jun;15(12):1976-82
pubmed: 12099903
Front Neurol. 2013 Aug 13;4:114
pubmed: 23964266
PLoS One. 2015 Jul 29;10(7):e0133270
pubmed: 26222143
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10732-7
pubmed: 15247411
Biometrics. 1989 Mar;45(1):255-68
pubmed: 2720055
Front Immunol. 2019 Apr 24;10:819
pubmed: 31068932
Nat Neurosci. 2007 Jan;10(1):19-26
pubmed: 17189949